Home › Compare › RNUGF vs EQR

RNUGF vs EQR: Dividend Comparison 2026

RNUGF yields 181818.18% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RNUGF wins by $1.8951031795759825e+29M in total portfolio value
10 years
RNUGF
RNUGF
● Live price
181818.18%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.8951031795759825e+29M
Annual income
$189,305,502,041,192,720,000,000,000,000,000,000.00
Full RNUGF calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — RNUGF vs EQR

📍 RNUGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRNUGFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RNUGF + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
RNUGF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RNUGF
Annual income on $10K today (after 15% tax)
$15,454,545.45/yr
After 10yr DRIP, annual income (after tax)
$160,909,676,735,013,800,000,000,000,000,000,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, RNUGF beats the other by $160,909,676,735,013,800,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RNUGF + EQR for your $10,000?

RNUGF: 50%EQR: 50%
100% EQR50/50100% RNUGF
Portfolio after 10yr
$9.475515897879912e+28M
Annual income
$94,652,751,020,596,360,000,000,000,000,000,000.00/yr
Blended yield
99.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

RNUGF
No analyst data
Altman Z
-38.7
Piotroski
2/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RNUGF buys
0
EQR buys
0
No recent congressional trades found for RNUGF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRNUGFEQR
Forward yield181818.18% ✓4.73%
Annual dividend / share$2.00$2.77 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$1.8951031795759825e+29M$40.5K ✓
Annual income after 10y$189,305,502,041,192,720,000,000,000,000,000,000.00 ✓$3,819.61
Total dividends collected$1.8949690612486723e+29M$16.9K ✓
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: RNUGF vs EQR ($10,000, DRIP)

YearRNUGF PortfolioRNUGF Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$18,192,518$18,181,818.18$11,248$547.57+$18.18M → RNUGF
2$30,932,835,887$30,913,369,892.64$12,701$666.53+$30932.82M → RNUGF
3$49,156,619,660,049$49,123,521,525,649.34$14,405$814.59+$49156619.65M → RNUGF
4$73,009,768,971,452,110$72,957,171,388,415,860.00$16,413$999.84+$73009768971.44M → RNUGF
5$101,348,671,691,011,770,000$101,270,551,238,212,300,000.00$18,795$1,232.92+$101348671691011.75M → RNUGF
6$131,490,628,941,834,950,000,000$131,382,185,863,125,600,000,000.00$21,639$1,527.95+$131490628941834960.00M → RNUGF
7$159,445,709,700,484,420,000,000,000$159,305,014,727,516,640,000,000,000.00$25,057$1,903.80+$159445709700484431872.00M → RNUGF
8$180,706,560,655,892,340,000,000,000,000$180,535,953,746,512,850,000,000,000,000.00$29,197$2,385.87+$1.8070656065589233e+23M → RNUGF
9$191,416,744,304,199,340,000,000,000,000,000$191,223,388,284,297,560,000,000,000,000,000.00$34,250$3,008.70+$1.9141674430419936e+26M → RNUGF
10$189,510,317,957,598,240,000,000,000,000,000,000$189,305,502,041,192,720,000,000,000,000,000,000.00$40,467$3,819.61+$1.8951031795759825e+29M → RNUGF

RNUGF vs EQR: Complete Analysis 2026

RNUGF — Stock

ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized packages of information released by CTX cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. The company was founded in 1997 and is headquartered in Pencoed, the United Kingdom.

Full RNUGF Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this RNUGF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RNUGF vs SCHDRNUGF vs JEPIRNUGF vs ORNUGF vs KORNUGF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.